Following his nomination in November, Pence called on the Senate to reject Kennedy, saying he would be “the most pro-abortion Republican appointed secretary of HHS in modern history” if confirmed.

Copyright 2025 The Associated Press. All Rights Reserved. President Donald Trump talks about drug prices during a visit to the Department of Health and Human Services ...

HHS Sec­re­tary nom­i­nee Robert F. Kennedy Jr. will di­vest his in­ter­ests in sev­er­al bio­phar­ma com­pa­nies, in­clud­ing CRISPR Ther­a­peu­tics and Drag­on­fly Ther­a ...

1, according to a memo from the acting secretary. The memo, which was sent to agency leaders by acting HHS Secretary Dorothy Fink, outlines that the HHS agencies should refrain from sending any ...

Kennedy Jr., President-elect Donald Trump’s pick for HHS secretary, undergoes Senate confirmation. Kennedy’s confirmation hearings are still not scheduled, and he is facing bipartisan pressure ...

Sanjay Gupta every Friday from the CNN Health team. The first direction Tuesday was given by Stefanie Spear, a deputy chief of staff at HHS who joined the agency this week, according to the Post.

The Trump administration has put a freeze on many federal health agency communications with the public through at least the end of the month. In a memo obtained by The Associated Press, acting ...

During Trump's first administration, prior to the overturning of Roe v. Wade, HHS took actions to reduce abortion, including reinstating and expanding a policy that bars foreign non-government ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...

The Washington Post: Trump Team Taps Dorothy Fink To Serve As Interim HHS Secretary Incoming Trump officials have tapped Dorothy Fink, an endocrinologist and career civil servant, as the interim ...

The U.S. Department of Health and Human Services’ (HHS') Biomedical Advanced Research and Development Authority (BARDA) has been working with Moderna since 2023 to help develop mRNA vaccines ...